Follow
Hartmut Döhner
Hartmut Döhner
Professor of Medicine
Verified email at uniklinik-ulm.de
Title
Cited by
Cited by
Year
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
H Döhner, E Estey, D Grimwade, S Amadori, FR Appelbaum, T Büchner, ...
Blood, The Journal of the American Society of Hematology 129 (4), 424-447, 2017
56482017
Genomic aberrations and survival in chronic lymphocytic leukemia
H Döhner, S Stilgenbauer, A Benner, E Leupolt, A Kröber, L Bullinger, ...
New England Journal of Medicine 343 (26), 1910-1916, 2000
43102000
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
H Döhner, EH Estey, S Amadori, FR Appelbaum, T Büchner, AK Burnett, ...
Blood, The Journal of the American Society of Hematology 115 (3), 453-474, 2010
42582010
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National …
M Hallek, BD Cheson, D Catovsky, F Caligaris-Cappio, G Dighiero, ...
Blood, The Journal of the American Society of Hematology 111 (12), 5446-5456, 2008
38952008
Genomic classification and prognosis in acute myeloid leukemia
E Papaemmanuil, M Gerstung, L Bullinger, VI Gaidzik, P Paschka, ...
New England Journal of Medicine 374 (23), 2209-2221, 2016
38572016
Acute myeloid leukemia
H Döhner, DJ Weisdorf, CD Bloomfield
New England Journal of Medicine 373 (12), 1136-1152, 2015
34312015
Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic …
BD Cheson, JM Bennett, KJ Kopecky, T Büchner, CL Willman, EH Estey, ...
Journal of clinical oncology 21 (24), 4642-4649, 2003
30072003
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
M Hallek, K Fischer, G Fingerle-Rowson, AM Fink, R Busch, J Mayer, ...
The Lancet 376 (9747), 1164-1174, 2010
23722010
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
RM Stone, SJ Mandrekar, BL Sanford, K Laumann, S Geyer, ...
New England Journal of Medicine 377 (5), 454-464, 2017
20972017
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia
RF Schlenk, K Döhner, J Krauter, S Fröhling, A Corbacioglu, L Bullinger, ...
New England Journal of Medicine 358 (18), 1909-1918, 2008
20672008
Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions
V Goede, K Fischer, R Busch, A Engelke, B Eichhorst, CM Wendtner, ...
New England Journal of Medicine 370 (12), 1101-1110, 2014
18962014
Acute myeloid leukaemia
E Estey, H Döhner
The Lancet 368 (9550), 1894-1907, 2006
17812006
Azacitidine and venetoclax in previously untreated acute myeloid leukemia
CD DiNardo, BA Jonas, V Pullarkat, MJ Thirman, JS Garcia, AH Wei, ...
New England Journal of Medicine 383 (7), 617-629, 2020
17382020
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia
F Lo-Coco, G Avvisati, M Vignetti, C Thiede, SM Orlando, S Iacobelli, ...
New England Journal of Medicine 369 (2), 111-121, 2013
1633*2013
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
M Hallek, BD Cheson, D Catovsky, F Caligaris-Cappio, G Dighiero, ...
Blood, The Journal of the American Society of Hematology 131 (25), 2745-2760, 2018
15632018
Matrix‐based comparative genomic hybridization: biochips to screen for genomic imbalances
S Solinas‐Toldo, S Lampel, S Stilgenbauer, J Nickolenko, A Benner, ...
Genes, chromosomes and cancer 20 (4), 399-407, 1997
14211997
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with> 30% blasts
H Dombret, JF Seymour, A Butrym, A Wierzbowska, D Selleslag, JH Jang, ...
Blood, The Journal of the American Society of Hematology 126 (3), 291-299, 2015
12912015
Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia
L Bullinger, K Döhner, E Bair, S Fröhling, RF Schlenk, R Tibshirani, ...
New England Journal of Medicine 350 (16), 1605-1616, 2004
12422004
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
MA Sanz, D Grimwade, MS Tallman, B Lowenberg, P Fenaux, EH Estey, ...
Blood, The Journal of the American Society of Hematology 113 (9), 1875-1891, 2009
11602009
Mutations driving CLL and their evolution in progression and relapse
DA Landau, E Tausch, AN Taylor-Weiner, C Stewart, JG Reiter, J Bahlo, ...
Nature 526 (7574), 525-530, 2015
11232015
The system can't perform the operation now. Try again later.
Articles 1–20